InvestorsHub Logo
Followers 1610
Posts 118683
Boards Moderated 20
Alias Born 08/20/2006

Re: None

Monday, 04/01/2019 12:44:29 PM

Monday, April 01, 2019 12:44:29 PM

Post# of 19450
$SOAN NEWS! AngioSoma Announces New Facility in San Antonio for Diabetes Relief
9:30 AM ET 4/1/19 | GlobeNewswire



AngioSoma Announces New Facility in San Antonio for Diabetes Relief

HOUSTON, TX, April 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announces that Diabetes Relief LLC has licensed a new facility in San Antonio, Texas for its patented treatment, which is about to open. "Diabetes Relief is proud of this facility, which is an important cog in our expansion wheel as we move further west into Texas," said Dr. Stanley T. Lewis, Chief Medical Officer. "We are anxious to help the thousands of diabetics in the San Antonio area, especially those with foot problems, who may have all but given up hope, " Dr. Lewis added.

According to the National Institutes of Health, foot problems, especially diabetic neuropathy, are common in people with diabetes. See more at www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/foot-problems. Testimonials from Diabetes Relief's patients (www.diabetesrelief.com) often include amazing improvements in neuropathy and foot ulcers after receiving the patented treatment.

The Diabetes Relief protocol treats insulin resistance and improves insulin sensitivity with an approach that is not satisfied with treating only symptoms but goes to the root cause of metabolic disorder, where conventional treatment has failed. Diabetes Relief now has licensed clinics in Texas, Utah, California, Georgia, Florida, Turkey, Azerbaijan and Lebanon, with others planned in the U.S. and abroad.

ABOUT DIABETES RELIEF LLC

Diabetes Relief LLC is a privately-held company that began in 2015 with one facility in Houston and has received a letter of intent and is exploring the possibility of a business combination with AngioSoma. Diabetes Relief's patented process helps patients with all metabolic disorders, dominated by diabetes. Patients report improvements with Diabetes Relief's physiologic insulin administration that they have found nowhere else and with no other treatment or prescription drugs. Its rapidly growing licensees now provide services and products in 5 states and 3 other countries that promote healthier living and an improved quality of life for those living with diabetes and other metabolic dysfunction. Information and patient testimonials are available at www.diabetesrelief.com.

ABOUT ANGIOSOMA, INC.

AngioSoma, Inc. (https://angiosoma.com), a Nevada corporation based in Houston, Texas, is dedicated to improving the mental and physical wellbeing of men and women. To accomplish that purpose, we are launching a line of supplements under our Somaceuticals(TM) common identity. Our supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.